“Roundtable Discussion: Navigating Challenging Treatment Decisions in Relapsed and Refractory Multiple Myeloma (RRMM)”. 2023. Canadian Hematology Today 2 (s07): 2–5. https://doi.org/10.58931/cht.2023.2s0736.